Preliminary results of a phase 2a clinical trial to evaluate safety, tolerability and antiviral activity of intravenous brincidofovir (BCV IV) in immunocompromised patients with adenovirus infection Meeting Abstract
| Authors: | Grimley, M.; Maron, G.; Gomez, C. A.; Prasad, V. K.; Dara, J.; Papanicolaou, G. A.; Fukushima, K.; Wynn, R. F.; Boeckh, M. |
| Abstract Title: | Preliminary results of a phase 2a clinical trial to evaluate safety, tolerability and antiviral activity of intravenous brincidofovir (BCV IV) in immunocompromised patients with adenovirus infection |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 112 |
| Language: | English |
| ACCESSION: | WOS:001159306700113 |
| DOI: | 10.1182/blood-2023-179901 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
